BNY Mellon put buyers hold firm as borrow costs stay elevated

BNY, up 1.4% over the past week, has outpaced most of its closest custody and asset management peers. STT gained 1.3%, NTRS added 1.4%, while GS, MS and IVZ all fell. The outperformance sits alongside signals that have not faded since the previous report five days ago.

Puts still dominate the options market

The put-call ratio stood at 1.918 on October 20, a 52-week high reported in the previous ORTEX convergence note. It has since eased to 1.869 as of October 23 but remains above the 20-day mean of 1.80 and 1.1 standard deviations above that mean. The cluster of daily readings above 1.85 stretching back to October 19 is the longest such run in the 52-week window. Put buyers are not retreating.

Borrow cost spiked and then pulled back

Cost to borrow jumped to 0.70% on October 21, up 254% in a week according to the ORTEX pulse. It has since settled to 0.38% as of October 22. The move is worth noting even after the retreat: the range this month has been wide, from a low of 0.035% on October 6 to that 0.70% peak. Availability remains effectively unlimited, the lending pool carries far more shares than current short demand requires, so the cost spike reflects episodic borrow demand rather than any structural squeeze. Short interest itself is just 1.20% of free float, down 17.8% over the past month, and is not a primary driver here.

Analyst targets have drifted lower

Citigroup's Benjamin Gerlinger lowered his target to $157 from $160 on October 19, keeping a Neutral rating. Truist's David Smith cut his target to $165 from $172 on October 16, also maintaining Buy. The consensus mean target is $163.33, against a current price of $145.27, implying roughly 12% upside. Targets have moved in one direction across most of the October notes: lower. That drift matches the stock's 3.3% decline over the past month, even as the week-to-date performance has recovered.

Retail attention remains elevated

Wikipedia views and ORTEX stock page traffic were running 4.7 standard deviations above their 90-day average as of October 21, the same reading flagged five days ago. ORTEX Alt Data classifies this as an attention signal, not a revenue or earnings indicator. No alt data dataset covering BNY carries a measured lead to its financials. The elevated engagement is unusual for a company whose institutional investor base dwarfs its retail following, with BlackRock holding 8.6% and Vanguard Capital Management 7.2% as of September 30.

The level to watch is the $157 Citi target: the stock has not traded above it since early October, and that gap will likely define whether analyst sentiment stabilises or continues sliding into the January 15 earnings date.